NCT07342478 2026-01-16ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLLNewave Pharmaceutical IncPhase 3 Not yet recruiting306 enrolled
NCT00824265 2020-06-18Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic LeukemiaNovartisPhase 3 Completed365 enrolled 28 charts